首页> 外文OA文献 >Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

【2h】

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

机译：依那末抑制素（一种醛糖还原酶抑制剂）对糖尿病周围神经病变的长期临床疗效3年，多中心，比较醛糖还原酶抑制剂 - 糖尿病并发症试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nigishi Hotta Md; Yasuo Akanuma Md; Ryuzo Kawamori Md; Kempei Matsuoka Md; Motoaki Shichiri Md; Mitsuyoshi Nakashima Md; Isao Yoshimura Phd;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. [J] . Hotta N, Akanuma Y, Kawamori R, Diabetes care . 2006,第7期

机译：醛糖还原酶抑制剂依帕司他对糖尿病周围神经病变的长期临床效果：为期3年的多中心比较性醛糖还原酶抑制剂-糖尿病并发症试验。
2. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: Multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy [J] . HottaN., KawamoriR., FukudaM., Diabetic medicine: A journal of the British Diabetic Association . 2012,第12期

机译：醛糖还原酶抑制剂依帕司他对糖尿病性神经病和其他微血管并发症进展的长期临床影响：基于患者背景因素和糖尿病性神经病的严重程度的多元流行病学分析
3. Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat. [J] . Hotta N, Kawamori R, Atsumi Y, Diabetic medicine: A journal of the British Diabetic Association . 2008,第7期

机译：用于选择适当靶向糖尿病外周神经病变的适当靶患者，用醛糖还原酶抑制剂，ECALRESTAT选择适当的靶向患者的糖尿病外周神经病变。
4. Effects of aldose reductase inhibitor in diabetic rats [C] . Nagai, T., Sekizuka, Engineering in Medicine and Biology Society, 1998. Proceedings of the 20th Annual International Conference of the IEEE . 1998

机译：醛糖还原酶抑制剂在糖尿病大鼠中的作用
5. Isolation and characterization of aldose reductase inhibitors from Wrightia tinctoria R.Br. seeds [D] . Kunaparaju, Naveen 2011

机译：Wrightia tinctoria R.Br.的醛糖还原酶抑制剂的分离和表征种子
6. Long-term clinical effects of epalrestat an aldose reductase inhibitor on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy [O] . N Hotta, R Kawamori, M Fukuda, -1

机译：醛糖还原酶抑制剂依帕司他对糖尿病性神经病和其他微血管并发症进展的长期临床影响：基于患者背景因素和糖尿病性神经病的严重程度的多元流行病学分析
7. Long‐term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy [O] . N. Hotta, R. Kawamori, M. Fukuda, 2012

机译：Epalrestat的长期临床疗效，醛糖还原酶抑制剂，糖尿病神经病变和其他微血管并发症的进展：基于患者背景因素的多变量流行病学分析及糖尿病神经病变的严重程度
8. Structural-Based Inhibitors of the Glutathione Binding Site in Aldose Reductase, Methods of Screening Therefor and Methods of Use. [R] . Srivastava, S. K., Bhatnagar, A., Ramana, K. V. 2005

机译：基于结构的醛糖还原酶中谷胱甘肽结合位点的抑制剂，筛选方法和使用方法。

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

著录项

引文网络

相似文献

相关主题

期刊订阅